Oruka Therapeutics earnings were -$78.1M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest ORKA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$21.0M, down 18.5% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, ORKA reported annual earnings of -$83.7M, with 1,468.2% growth.
What were Oruka Therapeutics's earnings last quarter?
On ORKA's earnings call on Invalid Date, Oruka Therapeutics (NASDAQ: ORKA) reported Q1 2025 earnings per share (EPS) of -$0.40, up N/A year over year. Total ORKA earnings for the quarter were -$21.00 million. In the same quarter last year, Oruka Therapeutics's earnings per share (EPS) was N/A.
As of the last Oruka Therapeutics earnings report, Oruka Therapeutics is currently losing money. Oruka Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$78.08 million, a N/A decrease year over year.
What was ORKA's earnings growth in the past year?
As of Oruka Therapeutics's earnings date in Invalid Date, Oruka Therapeutics's earnings has grown year over year. ORKA earnings in the past year totalled -$78.08 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.